Literature DB >> 10505711

Somatic electrical nerve stimulation regulates the motility of sphincter of Oddi in rabbits and cats: evidence for a somatovisceral reflex mediated by cholecystokinin.

J H Chiu1, Y L Kuo, W Y Lui, C W Wu, C Y Hong.   

Abstract

Cholecystokinin (CCK) plays an important role in regulating the biliary motility in herbivorous and carnivorous animals. Little is known about how the motility of the sphincter of Oddi (SO) is regulated through a somatic stimulation. It was our aim to test the hypothesis that somatic electrical nerve stimulation (SENS) affects SO motility in animals with different types of SO through CCK-related mechanisms. The activity of SO in anesthetized rabbits and cats was measured by using a continuously perfused open-tip manometric method. SENS was brought about by applying an electric current (2/15 Hz alternatively, 20 min) to two needles positioned near spinal nerves in the 6th and 7th intercostal space in the right midclavicular line. The SO motility before and X min after the start of SENS, designated as pre-SENS and SENS-X respectively, were recorded and saved in a computer equipped with off-line analysis software. The SO activity in rabbits, in terms of phasic contraction pressure and duration of summation peak during SENS were significantly higher than that before SENS. The phasic contraction pressure of pre-SENS, SENS-10, and SENS-16 were 6.83 +/- 0.39 mm Hg, 9.23 +/- 0.83 mm Hg and 10.46 +/- 0.81 mm Hg, respectively (P < 0.03, N = 13). The duration of summation peak in pre-SENS, SENS-10, and SENS-16 were 7.26 +/- 0.41 sec, 10.22 +/- 0.46 sec, and 13.49 +/- 2.31 sec, respectively (P < 0.05, N = 13). The SENS-induced SO hyperactivity was not inhibited by pretreatment with atropine, propranolol, phentolamine, or naloxone, but was blocked by pretreatment with the CCK receptor antagonist, proglumide, and by injection of anti-CCK-8 antibody during SENS in a dose-dependent manner. In contrast, SENS induced an inhibitory SO response in cats. However, in both circumstances, an obvious elevation of plasma CCK level determined by radioimmunoassay was noted after SENS. We conclude that SENS causes secretion of CCK, which in turn affects biliary tract motility in animals with different types of SO. This provides an easily applicable method for those patients who have hyperactive SO function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505711     DOI: 10.1023/a:1018870017774

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Effect of transcutaneous nerve stimulation on esophageal function in normal subjects--evidence for a somatovisceral reflex.

Authors:  F Y Chang; W Y Chey; A Ouyang
Journal:  Am J Chin Med       Date:  1996       Impact factor: 4.667

2.  Flow resistance in the feline choledocho-duodenal sphincter as studied by constant-pressure and constant-perfusion techniques.

Authors:  A Thune; L Jivegård; J Svanvik
Journal:  Acta Physiol Scand       Date:  1989-03

Review 3.  Hormonal control of sphincter of Oddi.

Authors:  J C Sarles
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

4.  Characterization of cholecystokinin receptors on the sphincter of Oddi.

Authors:  K L Cox; T von Schrenck; T H Moran; J D Gardner; R T Jensen
Journal:  Am J Physiol       Date:  1990-11

5.  The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia.

Authors:  M Guelrud; A Rossiter; P F Souney; S Mendoza; V Mujica
Journal:  Am J Gastroenterol       Date:  1991-05       Impact factor: 10.864

Review 6.  Sphincter of Oddi motility.

Authors:  J Toouli
Journal:  Br J Surg       Date:  1984-04       Impact factor: 6.939

7.  Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects.

Authors:  G Lux; J Hagel; P Bäcker; G Bäcker; R Vogl; H Ruppin; S Domschke; W Domschke
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

8.  Neural control of the sphincter of Oddi. Physiologic role of enkephalins on the regulation of basal sphincter of Oddi motor activity in the cat.

Authors:  J Behar; P Biancani
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

Review 9.  The assessment of depth of anaesthesia in animals and man.

Authors:  G Whelan; P A Flecknell
Journal:  Lab Anim       Date:  1992-07       Impact factor: 2.471

10.  Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans.

Authors:  A Slivka; R Chuttani; D L Carr-Locke; L Kobzik; D S Bredt; J Loscalzo; J S Stamler
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more
  5 in total

1.  Protective effect of electroacupuncture at the Neiguan point in a rabbit model of myocardial ischemia-reperfusion injury.

Authors:  Hongxing Zhang; Lingguang Liu; Guofu Huang; Li Zhou; Wenli Wu; Tangfa Zhang; Hao Huang
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

2.  Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro.

Authors:  Réka Sári; Attila Pálvölgyi; Zoltán Rakonczay; Tamás Takács; János Lonovics; László Czakó; Zoltán Szilvássy; Péter Hegyi
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  The study between the dynamics and the X-ray anatomy and regularizing effect of gallbladder on bile duct sphincter of the dog.

Authors:  Jing-Guo Wei; Yao-Cheng Wang; Guo-Min Liang; Wei Wang; Bao-Ying Chen; Jia-Kuan Xu; Li-Jun Song
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Different central manifestations in response to electroacupuncture at analgesic and nonanalgesic acupoints in rats: a manganese-enhanced functional magnetic resonance imaging study.

Authors:  Jen-Hwey Chiu; Mao-Shu Chung; Hui-Cheng Cheng; Tzu-Cheng Yeh; Jen-Chuen Hsieh; Chung-Yen Chang; Wan-Yo Kuo; Henrich Cheng; Low-Tone Ho
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

5.  How does moxibustion possibly work?

Authors:  Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.